1. Home
  2. VRAX vs MNDR Comparison

VRAX vs MNDR Comparison

Compare VRAX & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$1.24

Market Cap

1.5M

Sector

Health Care

ML Signal

HOLD

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$0.86

Market Cap

1.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
MNDR
Founded
2013
2016
Country
United Kingdom
Singapore
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.7M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
VRAX
MNDR
Price
$1.24
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
150.3K
★ 6.9M
Earning Date
11-20-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$497.01
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.40
52 Week High
$13.19
$5.67

Technical Indicators

Market Signals
Indicator
VRAX
MNDR
Relative Strength Index (RSI) 21.48 43.96
Support Level $0.16 $0.80
Resistance Level $3.01 $1.22
Average True Range (ATR) 0.29 0.54
MACD -0.05 -0.05
Stochastic Oscillator 2.69 3.00

Price Performance

Historical Comparison
VRAX
MNDR

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

Share on Social Networks: